Partner News | Published: Friday, October 31, 2025
The study, "AI-Guided Quantitative Plaque Evaluation from CT to Identify Patients with Future Myocardial Infarction or Death," analyzed 6,550 symptomatic patients (48% male, mean age 59) over 4.4 years who underwent coronary computed tomography angiography (CCTA) with AI-based quantitative coronary CT analysis (AI-QCT) across international sites.
Partner News | Published: Wednesday, October 29, 2025
Kestra Medical Technologies, a wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using therapeutic intervention technologies that are intuitive, intelligent, and connected.
Partner News | Published: Tuesday, October 21, 2025
These latest updates build on the AMA CPT Editorial Panel's February 2025 decision to approve new Category III CPT codes for CaRi-Heart technology.
Partner News | Published: Tuesday, October 21, 2025
With this coverage breakthrough, more patients will benefit from Cleerly's ability to quantify and characterize coronary plaque noninvasively.
Partner News | Published: Tuesday, October 21, 2025
In his new role at PaceMate, he will drive the company’s AI ambitions forward with a focus on transforming data-driven insights into automatic actions, beginning with the transformation of manual workflows that slow down clinics and take up time that could be better spent on patients.
Partner News | Published: Tuesday, October 14, 2025
Basata, a healthcare technology company specializing in artificial intelligence (AI) solutions tailored to cardiology operations.
Partner News | Published: Monday, October 6, 2025
The coverage decision makes Cigna the latest major insurer to recognize the clinical and economic value of AI-Enabled CT-Based Quantitative Coronary Tomography (AI-QCT)/Coronary Plaque Analysis (AI-CPA) technology for cardiovascular care.
Partner News | Published: Wednesday, October 1, 2025
Health Elements, a healthcare technology company specializing in artificial intelligence (AI)-driven data abstraction.
Partner News | Published: Monday, September 8, 2025
ALYKA Health, a company leveraging mobile technology and behavioral science to close gaps in cardiovascular care between clinic visits.
Partner News | Published: Thursday, September 4, 2025
Cleerly presented late-breaking results from the CONFIRM2 registry, which demonstrated that the addition of AI-based quantitative Coronary CT Angiography (AI-QCT) significantly improved risk discrimination compared to models combining other clinical predictors such as CAD-RADS 2.0, coronary artery calcium score (CAC), and DUKE CAD index used for predicting Major Adverse Cardiovascular Events (MACE).
By continuing to use our site, you agree to our Cookie Policy, Privacy Policy and Terms of Use.